Overall rank by patents
#21,886
of 49,997 tracked assignees
USPTO PatentsView assignee record - 13 granted patents across 9 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).
The verdict
According to USPTO PatentsView, Terumo ranks #21,886 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 9 technology areas.
USPTO PatentsView assignee plate
Corpus R21886 · US Corporation #21,886 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Techspace Aero S.A. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Terumo BCT Biotechno… · this assignee
53 score
3D Lighting… · lowest
7 score
What this shows Terumo's Innovation Score is 52.6/100 (top 10% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Terumo BCT Biotechnologies, LLC is a focused PatentsView assignee: 9 CPC subclasses with 76.9% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2023 (8 grants) versus a trough of 1 in 2020. By volume, Terumo sits between Techspace Aero S.A. and The Board of Trustees of the University of Alabama, for and on behalf of the University of Alabama in Huntsville.
Terumo BCT Biotechnologies, LLC shows 11 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Techspace Aero S.A.
13 patents
Tenaya Therapeutics, Inc.
13 patents
Teramount Ltd.
13 patents
Terra Quantum AG
13 patents
TestCard Ltd.
13 patents
Teva Branded Pharmaceutical Products R&D, Inc.
13 patents
The Armor All/STP Products Company
13 patents
The Board of Trustees of the University of Alabama, for and on behalf of the University of Alabama in Huntsville
13 patents
Terumo BCT Biotechnologies, LLC
13 patents
What this shows Terumo holds 13 patents at rank #21,923, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #21,923 in granted patent volume.
Other assignees with the most granted patents in Terumo's primary technology class.
Terumo's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
53 Top 10% higher than 90% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 7.7% |
| 2022 | 1 | 7.7% |
| 2023 | 8 | 61.5% |
| 2024 | 2 | 15.4% |
| 2025partial year | 1 | 7.7% |
Top 9 of 9 technology areas
Overall rank by patents
#21,886
of 49,997 tracked assignees
52.6 out of 100
What to do with this data
Terumo BCT Biotechnologies, LLC's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.